Spotlight On: Uvence

Published

Written by...

Share this article

Regenerative medicine has been the buzz term of the aesthetics field for some time now. Referring to the branch of medicine that aims to develop innovations to regrow, repair or replace damaged or diseased cells, organs or tissues, its use in aesthetics has often involved adipose-derived mesenchymal stem cells (ADMSC). These cells are collected via liposuction and the adipose sample undergoes a purification, emulsification and filtration protocol to isolate the stem cells.1,2,3 The literature suggests that these living cells have the ability to differentiate, regenerate and ‘turn back the clock’ once reinjected.4,5 However, for many aesthetic practitioners, the use of ADMSCs are not a viable option for their patients, preventing it from becoming a mainstream treatment in medical aesthetics.
Uvence is a relatively new concept pioneered and co-founded by London plastic, aesthetic and reconstructive surgeon Mr Olivier Amar and CEO Reece Tomlinson. It is a treatment approach that aims to…

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.